Atossa Therapeutics Inc (ATOS)

Jun 15, 2025

Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Jun 15, 2025

Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025

Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Jun 07, 2025

Jun 07, 2025

Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World

Jun 07, 2025

Jun 06, 2025

Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus

Jun 06, 2025

Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 By Investing.com - Investing.com India

Jun 06, 2025

Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 - Investing.com

Jun 06, 2025

Jun 06, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (BMV:ATOS) with Buy Recommendation - Nasdaq

Jun 06, 2025

Jun 05, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (ATOS) with Buy Recommendation - Nasdaq

Jun 05, 2025

Jun 05, 2025

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 05, 2025

Jun 05, 2025

Craig-Hallum Initiates Coverage on Atossa Therapeutics (ATOS) with Buy Rating | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics at Jefferies Conference: Strategic Moves in Breast Cancer - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

Craig-Hallum initiates Atossa Genetics stock with buy rating By Investing.com - Investing.com UK

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Ca - GuruFocus

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Cancer Drug Potential | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

Craig Hallum Initiates Coverage on Atossa Therapeutics With Buy Rating, $4 Price Target - MarketScreener

Jun 05, 2025

Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Positive Coverage and Price Target | ATOS Stock News - GuruFocus

Jun 05, 2025

Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference - Bluefield Daily Telegraph

Jun 02, 2025

Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference | ATOS Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

Atossa Therapeutics CEO Reveals Latest Breast Cancer Drug Progress at Major Healthcare Conference - Stock Titan

Jun 02, 2025

May 30, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Acquired by Northern Trust Corp - Defense World

May 30, 2025

May 28, 2025

Atossa Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025

May 22, 2025

Atossa Therapeutics CEO Steven Quay buys $9,886 in common stock - Investing.com Australia

May 22, 2025

May 22, 2025

Atossa Therapeutics CEO Steven Quay buys $9,886 in common stock By Investing.com - Investing.com Nigeria

May 22, 2025

May 22, 2025

Transcript : Atossa Therapeutics, Inc.Special Call - marketscreener.com

May 22, 2025

May 22, 2025

Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 - ACCESS Newswire

May 22, 2025

May 20, 2025

Atossa Therapeutics announces issuance of U.S. patent - MSN

May 20, 2025

May 20, 2025

Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | ATOS Stock News - GuruFocus

May 20, 2025

May 20, 2025

Atossa CEO to Reveal Latest Phase 2 Results for Next-Gen Breast Cancer Drug in Exclusive Investor Webinar - Stock Titan

May 20, 2025

May 18, 2025

HC Wainwright Issues Optimistic Outlook for ATOS Earnings - Defense World

May 18, 2025

May 15, 2025

Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year? - Yahoo Finance

May 15, 2025

May 14, 2025

Atossa Therapeutics (ATOS) Reports Promising Phase 2 Trial Resul - GuruFocus

May 14, 2025

May 14, 2025

Atossa Therapeutics Announces Full Results from I?SPY?2 Endocrin - GuruFocus

May 14, 2025

May 14, 2025

Atossa Therapeutics Announces Full Results from I‑SPY 2 Endocrine‑Optimization Sub‑Study Evaluating Low‑Dose (Z)‑Endoxifen - StreetInsider

May 14, 2025

May 14, 2025

Wells Fargo & Company MN Has $68,000 Stake in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 14, 2025

May 14, 2025

Phase 2 Trial: New Breast Cancer Drug Achieves 77.7% Tumor Shrinkage with Minimal Side Effects - Stock Titan

May 14, 2025

May 13, 2025

Atossa Therapeutics Announces First Quarter 2025 Financial Resul - GuruFocus

May 13, 2025

May 13, 2025

Atossa Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025

May 13, 2025

Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update - goSkagit

May 13, 2025

May 13, 2025

ATOSSA THERAPEUTICS, INC. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update | ATOS Stock News - GuruFocus

May 13, 2025

May 13, 2025

Barclays PLC Has $181,000 Holdings in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 13, 2025

May 10, 2025

Atossa Therapeutics (ATOS) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025

May 08, 2025

Atossa Therapeutics reports progress in breast cancer treatments - MSN

May 08, 2025

May 05, 2025

Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - standard-journal.com

May 05, 2025

May 03, 2025

JPMorgan Chase & Co. Buys 211,654 Shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 03, 2025

May 02, 2025

ATOS: Atossa Therapeutics Secures New Patent for (Z)-endoxifen F - GuruFocus

May 02, 2025

May 02, 2025

ATOS: Atossa Therapeutics Secures New Patent for (Z)-endoxifen Formulations | ATOS Stock News - GuruFocus

May 02, 2025

May 02, 2025

A look into Atossa Therapeutics Inc (ATOS)’s deeper side - Sete News

May 02, 2025

May 02, 2025

LPL Financial LLC Cuts Stock Position in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

May 02, 2025